Showing results (61-70 of 266) with videos related to
Sort By:
Pageof 27
Experimental and Molecular Pathology|August 16, 2011
Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migrationBernd Schnabl, Daniela Valletta, Georgi Kirovski, et al.The Journal of Clinical Investigation|April 1, 2025
Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovationsBernd Schnabl, Christopher J Damman, Rotonya M CarrJournal of Clinical Gastroenterology|October 9, 2015
Role of Gut Microbiota in Liver DiseaseDavid A Brenner, Yong-Han Paik, Bernd SchnablWorld Journal of Gastroenterology|September 21, 2020
Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in miceSena Bluemel, Yanhan Wang, Suhan Lee, et al.Hepatology (Baltimore, Md.)|April 6, 2023
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.Methods and Protocols|November 21, 2023
Development of a Quantitative PCR Method for Detecting Enterococcus faecalis Cytolysin in Human Stool SamplesNoemí Cabré, Yongqiang Yang, Yanhan Wang, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|February 16, 2019
Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful eitherPhillipp Hartmann, Huikuan Chu, Yi Duan, et al.International Journal of Molecular Sciences|December 10, 2021
Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver DiseaseLuca Maccioni, Isabelle A Leclercq, Bernd Schnabl, et al.Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11COwen M Siggs, Bernd Schnabl, Bill Webb, et al.Journal of Gastroenterology and Hepatology|February 22, 2011
CXCL5 plasma levels decrease in patients with chronic liver diseaseFrank Tacke, Henning W Zimmermann, Christian Trautwein, et al.Pageof 27